(FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | |
---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||
Cash flow from continuing operating activities | -561.18K | -183.87K | -159.73K | -128.96K | -88.62K |
Net income from continuing operations | ---991.62K | ---541.88K | ---197.64K | ---124.29K | ---127.8K |
Asset impairment expenditure | --0 | ---- | ---- | ---- | --0 |
Remuneration paid in stock | --389.94K | ---- | ---- | ---- | ---- |
Other non cashItems | ---108.11K | ---145.48K | --20.33K | --8.64K | --8.4K |
Change In working capital | --84.49K | --49.44K | --17.58K | ---13.3K | --30.77K |
-Change in receivables | --35.44K | ---15.6K | ---4.65K | ---4.33K | --60.01K |
-Change in prepaid assets | --17K | --14.5K | --0 | --11K | ---8.5K |
-Change in payables and accrued expense | --32.06K | --50.54K | --22.23K | ---19.97K | ---20.74K |
Cash from discontinued investing activities | |||||
Operating cash flow | ---625.29K | ---247.99K | ---159.73K | ---128.96K | ---88.62K |
Investing cash flow | |||||
Cash flow from continuing investing activities | -179.51K | -43.59K | -10K | -81.56K | -44.37K |
Net PPE purchase and sale | ---179.51K | ---43.59K | ---10K | ---81.56K | ---44.37K |
Cash from discontinued investing activities | |||||
Investing cash flow | ---179.51K | ---43.59K | ---10K | ---81.56K | ---44.37K |
Financing cash flow | |||||
Cash flow from continuing financing activities | 369.09K | 0 | 0 | ||
Net common stock issuance | --300.24K | ---- | ---- | --0 | --0 |
Proceeds from stock option exercised by employees | --101.76K | ---- | ---- | ---- | ---- |
Net other financing activities | ---32.91K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | |||||
Financing cash flow | --369.09K | ---- | ---- | --0 | --0 |
Net cash flow | |||||
Beginning cash position | --1.15M | --636.78K | --806.51K | --1.02M | --1.15M |
Current changes in cash | ---435.71K | --77.52K | ---169.73K | ---210.51K | ---132.99K |
End cash Position | --714.3K | --714.3K | --636.78K | --806.51K | --1.02M |
Free cash from | ---804.8K | ---291.58K | ---169.73K | ---210.51K | ---132.99K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.